Ali Nowroozi

Ali Nowroozi

Auto-generated profile, based on publicly available information

Ali Nowroozi

Department of Radiology and Biomedical Imaging, University of California, San Francisco (UCSF), CA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in Rheumatology and Therapy
Verified
Journal Article
Open access
PDF file
SMSara Momtazmanesh
Sara Momtazmanesh
ANAli Nowroozi
Ali Nowroozi
NRNima Rezaei
Nima Rezaei
Investigation of the potential applications of artificial intelligence (AI), including machine learning (ML) and deep learning (DL) techniques, is an exponentially growing field in medicine and healthcare. These methods can be critical in providing high-quality care to patients with chronic rheumatological diseases lacking an optimal treatment, like rheumatoid arthritis (RA), which is the second most prevalent autoimmune disease. Herein, following reviewing the basic concepts of AI, we summarize the advances in its applications in RA clinical practice and research. We provide directions for future investigations in this field after reviewing the current knowledge gaps and technical and ethical challenges in applying AI. Automated models have been largely used to improve RA diagnosis since the early 2000s, and they have used a wide variety of techniques, e.g., support vector machine, random forest, and artificial neural networks. AI algorithms can facilitate screening and identification of susceptible groups, diagnosis using omics, imaging, clinical, and sensor data, patient detection within electronic health record (EHR), i.e., phenotyping, treatment response assessment, monitoring disease course, determining prognosis, novel drug discovery, and enhancing basic science research. They can also aid in risk assessment for incidence of comorbidities, e.g., cardiovascular diseases, in patients with RA. However, the proposed models may vary significantly in their performance and reliability. Despite the promising results achieved by AI models in enhancing early diagnosis and management of patients with RA, they are not fully ready to be incorporated into clinical practice. Future investigations are required to ensure development of reliable and generalizable algorithms while they carefully look for any potential source of bias or misconduct. We showed that a growing body of evidence supports the potential role of AI in revolutionizing screening, diagnosis, and management of patients with RA. However, multiple obstacles hinder clinical applications of AI models. Incorporating the machine and/or deep learning algorithms into real-world settings would be a key step in the progress of AI in medicine.

21 April 2024 in Clinical Radiology
Verified
Journal Article
Closed access
ANA. Nowroozi
A. Nowroozi
MSMohammad Amin Salehi
Mohammad Amin Salehi
PSParnian Shobeiri
Parnian Shobeiri
SAS. Agahi
S. Agahi
SMSara Momtazmanesh
Sara Momtazmanesh
MKMannudeep K. Kalra
Mannudeep K. Kalra

1 November 2020 in Indian Heart Journal
Verified
Journal Article
Open access
EMEsmaeil Mehraeen
Esmaeil Mehraeen
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
ANAli Nowroozi
Ali Nowroozi
Omid DadrasOmid Dadras
Omid Dadras
SASanam Alilou
Sanam Alilou
AKAmirali Karimi
Amirali Karimi
Since the epidemic of COVID-19 attractedthe attention, reports were surrounding electrocardiographic changes in the infected individuals. We aimed at pinpointing different observed ECG findings and discussing their clinical significance. We conducted a systematic search in PubMed, Embase, and Scopus databases. We included eligible original papers, reports, letters to the editors, and case reports published from December 2019 to May 10, 2020. The team identified 20 articles related to this topic. We divided them into articles discussing drug-induced and non-drug-induced changes. Studies reported an increased risk of QTc interval prolongations influenced by different therapies based on chloroquine, hydroxychloroquine, and azithromycin. Although these medications increased risks of severe QTc prolongations, they induced no arrhythmia-related deaths. In the non-drug-induced group, ST-T abnormalities, notably ST elevation, accounted for the most observed ECG finding in the patients with COVID-19, but their relation with myocardial injuries was under dispute. This systematic review suggests that identifying ECG patterns that might be related to COVID-19 is vital. Provided that physicians do not recognize these patterns, they might erroneously risk the lives of their patients. Furthermore, important drug-induced ECG changes provide awareness to the health-care workers on the risks of possible therapies.

1 March 2022 in Survey of Ophthalmology
Verified
Journal Article
Closed access
MSMohammad Amin Salehi
Mohammad Amin Salehi
ANAli Nowroozi
Ali Nowroozi
MGMahdi Gouravani
Mahdi Gouravani
SMSoheil Mohammadi
Soheil Mohammadi
JAJ. Fernando Arévalo
J. Fernando Arévalo

1 April 2022 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
MGMohammadreza Ghahari
Mohammadreza Ghahari
ASAbolfazl Salari
Abolfazl Salari
MYMahmood Ghafoori Yazdi
Mahmood Ghafoori Yazdi
ANAli Nowroozi
Ali Nowroozi
AFAmirreza Fotovat
Amirreza Fotovat
EAErfan Amini
Erfan Amini

1 December 2021 in Epilepsy Research
Verified
Journal Article
Closed access
ANAli Nowroozi
Ali Nowroozi
MSMohammad Amin Salehi
Mohammad Amin Salehi
SMSoheil Mohammadi
Soheil Mohammadi